Viatris Inc. is a global healthcare company. The Company has four segments: Developed Markets, Greater China, JANZ and Emerging Markets. Developed Markets segment comprises its operations primarily in North America and Europe. Greater China segment includes its operations in China, Taiwan and Hong Kong. JANZ segment reflects its operations in Japan, Australia and New Zealand. Emerging Markets segment encompasses its presence in approximately 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East, as well as its anti-retroviral franchise. Its portfolio comprises approximately 1,400 approved molecules across a range of key therapeutic areas, including globally recognized iconic and key brands, generics, complex generics, and biosimilars. It operates approximately 40 manufacturing sites worldwide, which produces oral solid doses, injectables, complex dosage forms and active pharmaceutical ingredients.
52 Week high
52 Week low
Zacks Investment Research • 1 day ago • VTRSViatris (VTRS) to Divest Some More Businesses, Shares Gain
Reuters • 3 days ago • VTRSDrugmaker Viatris to divest some of its businesses
The Motley Fool • 5 days ago • VTRSCould Viatris Stock Help You Become a Millionaire?
Seeking Alpha • 5 days ago • VTRSViatris: Generic Semaglutide Could Become The Poor Man's Option For Weight Loss
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.